Morisset Valerie
EVP, R&D AND CSO at CLYM
- Sold, on record
- $3.4M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jul 22, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLYMClimb Bio, Inc.EVP, R&D AND CSO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CLYMNo planJul 3, 2024 2024
Sold 50,000 shares at $6.76 ($338k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 9.7% of holdings ($3.5M position)462,956 shares leftFirst sale on recordFiling
- 2 Form 4 sale CLYMNo planJul 5, 2024 +2 days
Sold 12,342 shares at $7.06 ($87k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 2.7% of holdings ($3.3M position)450,614 shares leftFiling
- 3 Form 4 sale CLYMNo planJul 11, 2024 +6 days
Sold 105,931 shares at $6.95 ($737k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 23.5% of holdings ($3.1M position)344,683 shares leftFiling
- 4 Form 4 sale CLYMUnusualJul 15, 2024 +4 days
Sold 92,377 shares at $7.04 ($651k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 26.8% of holdings ($2.4M position)252,306 shares left1.8x usual sizeFiling
- 5 Form 4 sale CLYMNo planJul 16, 2024 +1 day
Sold 50,000 shares at $7.13 ($357k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 19.8% of holdings ($1.8M position)202,306 shares left0.7x usual sizeFiling
- 6 Form 4 sale CLYMNo planJul 18, 2024 +2 days
Sold 41,783 shares at $6.93 ($289k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 20.7% of holdings ($1.4M position)160,523 shares left0.8x usual sizeFiling
- 7 Form 4 sale CLYMUnusualJul 22, 2024 +4 days
Sold 129,206 shares at $7.65 ($988k)
Morisset Valerie, EVP, R&D AND CSO
No 10b5-1 planSold 80.5% of holdings ($1.2M position)31,317 shares left2.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Jul 23, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 129,206 | $988k | 80.5% | Unusual | SEC |
| Jul 18, 2024 | Jul 19, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 41,783 | $289k | 20.7% | No plan | SEC |
| Jul 16, 2024 | Jul 17, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 50,000 | $357k | 19.8% | No plan | SEC |
| Jul 15, 2024 | Jul 16, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 92,377 | $651k | 26.8% | Unusual | SEC |
| Jul 11, 2024 | Jul 11, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 105,931 | $737k | 23.5% | No plan | SEC |
| Jul 5, 2024 | Jul 9, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 12,342 | $87k | 2.7% | No plan | SEC |
| Jul 3, 2024 | Jul 3, 2024 | CLYM | EVP, R&D AND CSO | Form 4 sale | 50,000 | $338k | 9.7% | No plan | SEC |